Evaluating the HEDIS Guidelines for Measuring Cervical Cancer Prevention Efforts.

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer screening quality is often measured using the Health Plan Employer Data and Information Set (HEDIS) age criteria.
• The National Committee for Quality Assurance (NCQA) promulgated these HEDIS criteria as a tool for assessing health plan performance.

Purpose of the Study:

• To evaluate the HEDIS age criteria (21-64 years) for cervical cancer screening.
• To assess if these criteria accurately reflect the risk of high-grade cervical disease in women outside the specified age range.

Main Methods:

• A prospective database of women undergoing colposcopy was analyzed.
• Cytology, histology, and colposcopic impression results were compared between women within and outside HEDIS age specifications.
• Histology was defined as the highest-grade result within 8-26 months post-colposcopy.

Main Results:

• Women aged 14-20 years had significantly lower rates of high-grade cervical intraepithelial neoplasia (CIN2/CIN3) or cancer compared to women aged 21-64 (28% vs 29%).
• However, a notable 12% of adolescents aged 14-20 had CIN2/CIN3 or cancer, indicating a significant risk.
• Women over 64 years showed no difference in rates of CIN2/CIN3 or cancer compared to women aged 20-64.

Conclusions:

• Adolescents referred for colposcopy, while at lower risk than older women, still present with a significant frequency of high-grade cervical disease.
• The findings suggest that current HEDIS age criteria for cervical cancer screening may be too restrictive and could overlook at-risk adolescent populations.
• Screening should be considered for adolescents despite HEDIS recommendations due to the observed rates of CIN2/CIN3 and cancer.